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High-throughput sequencing of RNAs crosslinked to
Argonaute proteins reveals not only a multitude of
atypical miRNA binding sites but also of miRNA targets
with atypical functions, and can be used to infer
quantitative models of miRNA-target interaction strength.been reported: for example, the let-7 binding site in theIntroduction
In the vast landscape of cellular RNAs of widely different
sizes, microRNAs (miRNAs) are small (21 to 22 nucleotides
long) RNAs that guide Argonaute proteins to target RNAs
to post-transcriptionally regulate their expression [1,2].
lin-4 was the first miRNA to be reported and found to
inhibit the translation of the lin-14 mRNA at a critical stage
in the development of the worm Caenorhabditis elegans
[3,4]. It was the discovery of the evolutionarily conserved
let-7 miRNA [5,6], however, that sparked a tremendous
interest in RNAs with regulatory functions. Through many
studies, a large catalog of miRNAs has since been compiled,
from species as evolutionarily distant as viruses and mam-
mals [7]. In the canonical biogenesis pathway, miRNAs are
transcribed by the RNA polymerase II (Pol II) as long
pri-miRNA. These are processed through two endonucleo-
lytic steps involving RNase III enzymes [8], the first carried
out by the Drosha-DiGeorge syndrome critical region 8
(DGCR8) complex in the nucleus to produce pre-miRNAs,
and the second by the Dicer-TAR (HIV-1) RNA binding
protein 2 (TRBP) complex in the cytoplasm to yield 21 to
22 nucleotide-long double-stranded RNAs. Typically one of
the two strands of the duplex is picked up by an Argonaute
protein to form a miRNA-guided RNA silencing complex
(miRISC). The biogenesis of miRNAs has been reviewed
extensively elsewhere [9]. Several alternative miRNA
biogenesis pathways have also been described. Mirtrons, for
example, bypass Drosha processing, being instead produced
from spliced introns by the activity of the lariat debranching
enzyme [10]. Another miRNA, pre-miR-451, is not processed* Correspondence: mihaela.zavolan@unibas.ch
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to yield the mature miRNA [11].
Many experimental and computational studies converged
on the 5′ end (about nucleotides 1 to 8) of the miRNA (also
known as the ‘seed’ region) being generally involved in
target recognition through perfect nucleotide complemen-
tarity (see [1] for a recent review). Exceptions have also
lin-41 3′ UTR, in which the nucleotide located between
those that base-pair with the fourth and fifth miRNA
nucleotide is looped out of the miRNA-target hybrid
[12,13]. Relatively rare sites that pair with the central region
of the miRNA have also been found [14] and the interest in
non-canonical miRNA target sites, which do not pair
perfectly with the miRNA seed region, persists [15,16].
Putative sites that are computationally predicted to imper-
fectly pair with the miRNA seed region due to a bulged
nucleotide in either the miRNA or the target site are known
to exhibit some degree of evolutionary conservation relative
to random 3′ UTR fragments of the same length [17,18].
However, the conservation signal as well as the apparent
effect of such sites on the stability of the target mRNAs is
smaller than those of canonical sites [19]. This likely
indicates that only a subset of these sites is functional.
Identifying this subset has so far been challenging.
Evolutionary studies of the Piwi-Argonaute-Zwille (PAZ)
domain-containing proteins revealed largely two clusters,
one corresponding to Argonaute and the other to the Piwi
proteins [20]. Members of these clusters appear to have
quite exquisite specificities for the length of the small RNAs
that they bind [21]. Sequencing of the populations of small
RNAs that associate with individual members of this
protein family has been recently used to identify not only
small guiding RNAs but also their targets. Here we review
the insights into the processing of small RNAs and into
their biological functions that were derived through high-
throughput studies, particularly those that investigated
individual protein components of small RNA-containing
regulatory pathways.entral Ltd. The licensee has exclusive rights to distribute this article, in any medium,
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non-coding RNA genes and targets
High-throughput sequencing has revolutionized molecular
biology, including the study of RNA. Taking advantage of
the biochemical properties of miRNAs (presence of a
5′-phosphate and 3′-hydroxyl), protocols have been devel-
oped to isolate and sequence these molecules with very little
background [22-24]. The approach consisted of isolation of
total RNA, followed by separation on urea-containing 15%
polyacrylamide gel along with a 32P-labelled ladder to allow
identification of RNAs of the appropriate size. After cutting
the corresponding band out of the gel and elution of
the RNA overnight, 3′ and 5′ adaptors were ligated, the
fragments concatamerized, and cDNA synthesized, PCR-
amplified, cloned into plasmid vectors and sequenced with
the Sanger method to yield 100 to 1,000 small RNAs per
sample. Next generation sequencing (NGS) greatly increased
the yield to 104 to 105 small RNA sequences per sample in
the initial studies employing this technology [25-27]. NGS-
based approaches have since been used to identify many
other types of small RNAs. The basic protocol remains
largely the same, except that cDNAs are sequenced without
cloning and concatamerization [28].
To further remove the background of processing prod-
ucts of abundant cellular RNAs as well as to gain more
direct insight into the functions of small RNAs, protocols
that employ the pulldown of the protein of interest with a
specific antibody have also been proposed (Figure 1). They
have been used in the discovery of miRNAs and various
other non-coding RNAs that associate with Argonaute pro-
teins [29,30]. Building on this approach, the Darnell group
[31,32] further applied a step of in vivo crosslinking using
ultraviolet (UV) C light (254 nm) of the RNA-binding
protein (RBP) to the RNAs with which it interacts in intact
cells or tissues. After cell lysis, the RNA is partially digested
to yield fragments in the range of 30 to 50 nucleotides, the
RNA-protein complex is immunoprecipitated with an anti-
body specific to the protein of interest, the RNA in the
complex is radioactively labeled at the 5′ end with 32P, and
an adapter is ligated at the 3′ end, after which the RNA-
protein complex is separated on an SDS gel and transferred
to a nitrocellulose membrane. This step results in the
removal of unbound RNAs and retention of the covalently
crosslinked RNA-protein complex. After the protein is
digested from the complex with proteinase K, a 5′ adapter
is ligated, cDNA is synthesized and PCR amplification is
carried out with primers complementary to 3′ and 5′
adapters. The PCR adapters also carry sequences needed
for attachment to the flowcell surface and for attachment
of the sequencing primers, when sequencing on Illumina
platforms. The resulting library is subjected to NGS.
To further improve the efficiency of capture of miRNA
targets, the Tuschl group proposed a modified protocol,
photoactivatable ribonucleoside-enhanced crosslinking andimmunoprecipitation (PAR-CLIP), in which photoactivata-
ble ribonucleoside analogues such as 4-thiouridine (4-SU)
or 6-thioguanosine (6-SG) are incorporated into RNAs
before crosslinking [33]. These modified nucleotides can be
efficiently crosslinked to proteins using UV A (365 nm).
In addition, crosslinking-diagnostic mutations (T-to-C or
G-to-A, respectively) are introduced during reverse tran-
scription to allow determination of the binding sites at
close-to-nucleotide resolution. This protocol has been
successfully used to identify not only miRNA targets
[33,34] but also the RNA targets of many RNA-binding
proteins [35]. To achieve the desired single-nucleotide
resolution in the identification of RBP targets, a method
that takes advantage of the propensity of reverse transcrip-
tase to stop at the position of crosslinking has been
proposed [36]. This individual nucleotide resolution CLIP
method (iCLIP) has only very recently been applied to the
characterization of small RNA-guided interactions [37].
Although high-throughput sequencing of RNA isolated by
crosslinking immunoprecipitation (HITS-CLIP), PAR-CLIP
and iCLIP have a similar basis, their differences make them
more or less applicable in specific contexts. For instance, an
important advantage of HITS-CLIP is that it can be per-
formed with relative ease in both cultured cells and living
tissues. However, the efficiency of crosslinking of Argonaute
to the mRNA targets (as opposed to the guide RNAs)
appears lower than with PAR-CLIP. Although PAR-CLIP is
more difficult to carry out in tissues, its successful applica-
tion to the identification of in vivo germline development
defective 1 (GLD-1) protein binding sites in the worm
C. elegans has been reported [38]. Important concerns about
the use of photoreactive nucleosides are that they are toxic
for cells [39] and they bias the set of binding sites that can
be identified. However, the concentration of 4-thiouridine
that has been used in PAR-CLIP experiments has not been
found to obviously affect the cells [33]. On the other hand,
the bias in binding site identification remains largely
unquantified. Yet this is not only an issue for PAR-CLIP
because crosslinking with 254 nm UV, as in HITS-CLIP, also
targets uridines preferentially [40].
Generally, it has become clear that crosslinking-induced
mutations are useful in separating the signal from noise
and identification of high-affinity binding sites [34,40,41],
but how different CLIP methods compare in this regard
needs to be further investigated. Several factors make this
comparison difficult. First, the protocols are lengthy and
difficult to master, which makes it difficult to obtain equally
good data with all the different CLIP protocols. Second, the
possible interplay between the biases of individual ap-
proaches and the sequence specificity of individual proteins
makes it necessary to perform the comparison on multiple
proteins. Third, it is non-trivial to obtain independent
quantifications of occupancies of individual binding sites by
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Figure 1 High-throughput methods for sequencing small RNAs and their targets. Conceptual protocols highlighting the differences between the
methods for deep sequencing of (a) small RNAs and of (b-e) small RNA targets (PAR-CLIP (b), CLASH (c), HITS-CLIP (d), iCLIP (e)). Ni-NTA, nickel nitrilotriacetic
acid; Gu-HCL, guanidine hydrochloride; PNK, polynucleotide kinase.
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in vitro-derived model of the sequence specificity of the
protein to predict its affinity for individual CLIPed sites
[34]. The success of this approach depends on how accur-
ately the affinity of RBP-RNA interactions can be predicted.
Another approach would be to take advantage of proteins
that establish crosslinks to RNA in a UV-independent
manner. For example, the NOP2/Sun domain family,
member 2 protein (NSUN2) normally catalyzes methylation
of cytosine to 5-methylcytosine, generating a protein-RNA
crosslink as an intermediate in the process. Employing a
variant that can no longer resolve the covalent bond that
the protein forms with the RNA, the binding sites of this
protein could be determined without UV crosslinking and
compared with the binding sites obtained by crosslinking
the protein to its sites with UV light. Finally, in the absence
of independent measures of site occupancy, comparisons of
sequence biases around putative binding sites inferred for
different proteins have been performed [40]. They indicatethat UVC light preferentially induces crosslinking of uri-
dines. Furthermore, it appears that reverse transcriptase
stoppage sites that are captured through iCLIP are a more
accurate indicator of protein binding sites than nucleotide
deletions that are introduced during HITS-CLIP.
Although the above-mentioned methods are able to iden-
tify the endogenous targets of miRNAs or other small non-
coding RNAs, they do not directly reveal which small RNA
guided the interaction of the RBP with individual targets.
To address this issue, another experimental approach has
been very recently proposed. It is known as crosslinking,
ligation and sequencing of hybrids (CLASH) and it relies
on the ligation of the guide RNA to the target RNA within
the ternary guide RNA-target RNA-RBP complex, after the
immunoprecipitation of the protein with the bound RNAs
[42]. In contrast to CLIP, this protocol includes, after
immunoprecipitation and partial digestion of the RNA in
the RNA-protein complex, a purification step based on a
6x-histidine epitope tag that allows denaturing purification
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guanidine-HCl. This ensures that only the RNA that is
covalently linked to protein is purified. In addition, an
inter-molecular RNA-RNA ligation step is introduced to
capture the target site and the miRNA from the RNA-
protein ternary complex. After elution of the RNA-protein
complex from nickel beads, the sample preparation pro-
ceeds similarly to CLIP. This method has been successfully
used to identify various types of RNA-RNA hybrids [43],
and its recent application to the Ago1 protein led to the
suggestion that different miRNAs may have different modes
of binding to their target mRNAs [42]. In its current form,
CLASH has very low efficiency, with only about 2% of the
reads obtained in an experiment corresponding to miRNA-
target hybrids. Furthermore, the use of a 6x-histidine tag
for the purification of RNA-protein complexes makes the
protocol applicable only to cells that express the tagged
protein.A






























Figure 2 The multi-faceted miRNA biogenesis and miRNA interaction wit
pathway, but also by the lariate-debranching enzyme in the nucleus, and by Di
in the cytoplasm. Although miRISC generally regulates the stability and translati
regulation by sequestering miRNAs from their direct targets.The expanding set of miRNA targets
Following the model of worm miRNAs, initial large-scale
studies of miRNA targets focused on mRNAs, first attempt-
ing to predict them computationally [44-46] and then to
determine them experimentally, by virtue of the change in
their expression upon miRNA transfection measured with
microarrays [47]. More recently, crosslinking-based approaches
are starting to bring a new understanding of miRNA-target
interactions and to uncover unusual targets (Figure 2).
Identification of non-canonical miRNA target sites from
CLIP data
miRNA target sites that do not perfectly pair with the
miRNA seed region (so-called non-canonical sites) have
been both described experimentally [5,12,15,48] and pre-
dicted based on evolutionary conservation [49]. However,
recent analyses of Ago2-CLIP data underscored the relative
























h targets.miRNAs are processed mainly by Drosha-DGCR8 in the canonical
cer (from other non-coding RNAs such as tRNAs and snoRNAs) and Ago2
on rate of target mRNAs, other long RNAs feed back on the miRNA
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the miRNA is looped out in the target [16,50]. More
importantly, CLIP provided sufficient data to infer a bio-
physical model of miRNA-target site interaction [19] that
allows, for the first time, a quantitative evaluation of the
strength of canonical and non-canonical interactions. As a
result, functional non-canonical target sites could be identi-
fied with high accuracy. They amounted to approximately a
quarter of the high-confidence, reproducibly CLIPed sites.
Perhaps as expected, abundant miRNAs were found to
have a higher proportion of non-canonical sites compared
with the less expressed miRNAs. A recent study that
captured and sequenced miRNA-target site pairs [42]
suggested that miRNAs differ widely in their propensity to
engage in non-canonical modes of interaction with their
targets. miR-92a, for example, a member of the abundantly
expressed miR-17/92 cluster of miRNAs, appeared to
predominantly pair with targets through its 3′ end region.
The response of these targets to the miR-92a depletion
was, however, smaller than that of seed-type miR-92a
targets, and thus the significance of these non-canonical in-
teractions remains to be determined. Nonetheless, as more
CLASH datasets emerge, it will be interesting to apply the
MIRZA inference procedure described in Khorshid et al.
[19] to CLASH data to infer miRNA-specific modes of
interaction with the targets. The MIRZA approach can be
further adapted to infer miRNA-target interaction parame-
ters from measurements of interaction affinity [51]. A
comparative analysis of models inferred from in vivo and
in vitro data should ultimately reveal the properties of
functionally relevant miRNA target sites.
Long non-coding RNA targets and miRNA sponges
Although the vast majority of Ago2 targets are mRNAs, a
variety of non-coding RNA targets have also been identi-
fied. For example, about 5% of the Ago2 targets obtained in
HITS-CLIP samples from mouse brain were long non-
coding RNAs (lncRNAs) [32], and many lncRNA-miRNA
interactions were also inferred from PAR-CLIP data of
different Argonaute proteins [52]. lncRNA-Argonaute
interactions (for example, between XIST lncRNA and
hsa-miR-370-3p) are documented in the starBase database
[53]. Rapidly emerging evidence points to a function of
lncRNA-miRNA interactions in regulating the availability
of the miRNA itself, with the lncRNA functioning as a
miRNA sponge.
miRNA sponges were introduced a few years ago [54]
as competitive miRNA inhibitors consisting of transgenic
RNAs that contain multiple putative binding sites for a given
miRNA or miRNA family. Perhaps not surprisingly, natural
miRNA sponges have emerged as well, initially among viral
transcripts. For example, a U-rich RNA of the Herpesvirus
saimiri acts as a sponge for the host miR-27 [55], as does
the m169 transcript of the murine cytomegalic virus [56]. Inmammals, pseudogenes such as PTENP1 and KRASP1 [57]
have been proposed to sponge miRNAs that would other-
wise act on the corresponding genes. It remains unclear,
however, whether under normal or disease conditions these
pseudogenes are expressed at sufficient levels to be effective
as sponges [58]. Other lncRNAs do appear to accumulate at
very high levels, consistent with a sponging function. For
example, a very recent study showed that the lncRNA H19
associates with the RISC complex, sequestering the let-7
miRNA and thereby modulating the expression of let-7
targets [59]. A similar interaction has been proposed to
occur between lincRNA-RoR and miR-145 [60].Circular RNA
miRNA sponges have also been found among circular
RNAs (circRNAs). Although a few circRNAs, such as
those derived from the DCC tumor suppressor gene
[61], the testis-determining SRY gene [62], ETS-1 [63]
and the cytochrome P450 gene 2C24 [64], were de-
scribed two decades ago, it was thought that such RNAs
are rare, aberrant products of the splicing reaction
[61,63]. Deep sequencing of RNAs from a variety of
normal and malignant cells revealed, however, an abun-
dance of such transcripts [65,66] that can be expressed
at 10-fold higher levels than the mRNAs derived
from the corresponding genes [67]. The biogenesis of
circRNA is not yet clear. Models such as lariat-driven or
intron-pairing-driven circularization have been proposed
[67]. Furthermore, failure in debranching can also
yield intron-derived circRNAs [68]. Interestingly, Ago2-
PAR-CLIP revealed that a circRNA that is antisense to
the cerebellar degeneration-related protein 1 transcript
(CDR1as) is densely bound by Argonaute proteins,
guided by a large number of conserved miR-7 binding
sites [69]. The circRNA is completely resistant to
miRNA-mediated target destabilization and it strongly
suppresses miR-7 activity in the mouse and zebrafish
brain [69,70]. Other functions of circRNAs, such as in
Pol II-dependent transcription, have also been reported
[68].
The adoption of high-throughput approaches is not
without complications. Every method has limited accuracy
and even in deep sequencing samples one expects a certain
amount of contaminating RNAs, particularly originating
from abundant cellular RNAs. Although a priori knowledge
of abundant RNA species generally helps in sifting away
this background, novel variants of well-studied molecules,
such as tRNA-derived fragments (tRFs) and small nucleolar
RNAs (snoRNAs), have also been identified recently,
complicating the analysis of deep-sequencing datasets. We
will describe here some non-canonically processed RNAs
with biological significance, whose number appears to be
more limited than initial analyses suggested [71-74].
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Application of Ago2-CLIP revealed a stress-dependent
remodeling of miRNA-target interactions, canonical inter-
actions becoming more prominent upon arsenite stress [75].
Increased Ago2 binding to these canonical sites was also as-
sociated with increased repression. The mechanism behind
the redistribution of Ago2 binding to higher affinity, canon-
ical sites under stress remains to be identified. The abun-
dance of both miRNAs and Ago2 protein appears to remain
unchanged between conditions and it was rather proposed
that signal-induced post-translational modifications of Ago2
may alter the interaction strength at specific sites. It is
conceivable that a reduction in RISC affinity for target sites
leads to reduced binding to weak, non-canonical sites. How-
ever, changes in the overall abundance of miRNA target sites
may also lead to changes in the stringency of competition
for a limited number of RISC complexes, and to a redistri-
bution of Ago2 between low- and high-affinity sites.
More roads leading to RISC
IsomiRs
Although mature miRNAs are typically processed very pre-
cisely from their precursor molecules, evidence is accumu-
lating that some miRNA variants - isomiRs - that differ in a
few nucleotides from the canonical, most frequently
observed sequence are generated and have biological
significance. Some isomiRs are templated, being the result
of imprecise cropping of miRNA precursors by Drosha or
Dicer [76] or of the trimming of the miRNA 3′ end by
3′-to-5′ exoribonucleases such as Nibbler in Drosophila
[77] and QIP in Neurospora [78]. The Dicer partner TRBP
can also modulate isomiR generation [79,80]. When the
miRNA is encoded in the 3′ arm of the pre-miRNA, the
Dicer-modulated change in isomiR abundance will likely
lead to a change in the spectrum of mRNAs that are
targeted by the miRNA. For example, the 5′ isomirs of
mir-307a do seem to have distinct targets because the
glycerol kinase and taranis mRNAs are repressed by
mir-307a23-mer but not by mir-307a21-mer [80]. Furthermore,
isomiRs and their canonical counterparts appear to associ-
ate equally with polysomal, translated RNA [81], indicating
that they may indeed function as miRNAs. A variety of
terminal nucleotidyl transferases, such as mitochondrial
poly(A) polymerase (MTPAP), PAP associated domain
containing (PAPD)4, PAPD5, zinc finger, CCHC domain
containing (ZCCHC)6, ZCCHC11 and terminal uridylyl
transferase 1, U6 snRNA-specific (TUT1) [82], have been
implicated in the generation of non-templated 3′ isomiRs.
TUT1-dependent addition of terminal U nucleotides has
been implicated in the regulation of miRNA stability [83].
snoRNA-derived small RNAs and tRFs
Sequencing of small RNA populations, including those that
specifically associate with RISC proteins, revealed fragmentsderived from abundantly expressed structural RNAs, such
as snoRNAs and tRNAs, that also seem to associate with
Argonaute proteins [29,84]. Among the snoRNAs, the
H/ACA box-type, which forms a typical two-hairpin
structure, gives rise to miRNA-like molecules that amount
to a few percent of the Argonaute-associated small RNA
population [84]. The H/ACA box snoRNA small Cajal
body-specific RNA 15 (SCARNA15) generates the most
abundant Ago2-associated snoRNA-derived small RNA,
which targets the transcript encoding the Mediator coactiva-
tor complex subunit cyclin-dependent kinase 19 (CDK19)
[29]. Although less abundant among the approximately 20
to 40 nucleotide-long RNAs in the cell, tRFs appear to asso-
ciate more efficiently with the Ago2 protein compared with
snoRNA-derived fragments [84]. Various nucleases have
been implicated in the generation of tRFs, starting with
Dicer, which processes the CU1276 tRF - which functions as
a miRNA in B cells, repressing the replication protein A1
[85] - and the tRF-5-GlnCTG [86]. Angiogenin acts at the
TψC loop to generate 3′-end tRFs, and on the anticodon
loop to produce 5′-end tRFs [87]. The latter have been
implicated in the eukaryotic translation initiation factor 2
alpha (eIF2α)-independent inhibition of translation in U2OS
cells upon stress [88]. Finally, the elaC ribonuclease Z 2
(ELAC2) endonuclease cleaves the 3′ trailer sequence
from Ser-TGA pre-tRNAs, generating the pro-proliferative
trf-1001 tRF [89].Cleaving without a guide
Although we have extensively discussed small RNA-guided
mRNA destabilization, the Drosha-DGCR8 complex that
processes pri-miRNAs also cleaves hairpin structures that
form within other molecules, including mRNAs, thereby
inducing their destabilization. The abundance of the
metastasis associated lung adenocarcinoma transcript 1
(non-protein coding) (MALAT1) non-coding RNA appears
to be controlled through this mechanism [90], as is the
expression of several genes that induce neuronal differenti-
ation, such as neurogenin 2 [91].Conclusions
The list of long and short functional RNAs is expanding
rapidly. Here we have summarized some of the insights into
the targets of the miRNA-dependent pathway that were ob-
tained particularly though NGS-based approaches such as
small RNA sequencing and different variants of RBP-CLIP
methods. An increasing number of entry points into
miRNA-dependent gene regulation are being discovered.
Furthermore, miRNA-target interactions are plastic, and
cell type- and condition-dependent. Nonetheless, quantita-
tive analyses in the context of computational models should
ultimately allow the behavior of this very complex gene
regulatory system to be understood and predicted.
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